Results-Based Financing Impact Evaluation Health Facility 2017, Endline Survey
Burkina Faso, 2017
Get MicrodataCreated on
Dec 05, 2019
Last modified
Dec 05, 2019
Page views
61281
Downloads
49
F7_220_M (f7_220_5)
Data file: f7_jul19
Overview
Valid:
147
Invalid:
0
Type:
Discrete
Start:
717
End:
741
Width:
25
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 8 |
5.4%
|
|
| 00 | 22 |
15%
|
|
| 2 | 2 |
1.4%
|
|
| 3 | 2 |
1.4%
|
|
| 4 | 1 |
0.7%
|
|
| 99 | 1 |
0.7%
|
|
| ASL | 2 |
1.4%
|
|
| ASL inj | 1 |
0.7%
|
|
| ASL injec | 1 |
0.7%
|
|
| ASL+HPV | 1 |
0.7%
|
|
| Albendazol cp | 1 |
0.7%
|
|
| Amoxi | 1 |
0.7%
|
|
| Amoxi gel | 1 |
0.7%
|
|
| Amoxicilline | 1 |
0.7%
|
|
| Ampi 1g | 1 |
0.7%
|
|
| COMPRESSE A GAZE STERILES | 1 |
0.7%
|
|
| Ceftriaxone | 1 |
0.7%
|
|
| Cloxa gel | 1 |
0.7%
|
|
| Compresse | 1 |
0.7%
|
|
| Cotrimoxazole | 1 |
0.7%
|
|
| EXPECTORAL | 1 |
0.7%
|
|
| FAF | 1 |
0.7%
|
|
| Furosemid cp | 1 |
0.7%
|
|
| Gant | 2 |
1.4%
|
|
| HPR | 1 |
0.7%
|
|
| HPV | 1 |
0.7%
|
|
| HYDROCORTIXONE | 1 |
0.7%
|
|
| Hydrocortisone | 1 |
0.7%
|
|
| Hydrortisone | 1 |
0.7%
|
|
| Hydroxyde d'aluminium | 1 |
0.7%
|
|
| Ibuprifène, Betadine | 1 |
0.7%
|
|
| Ibuprofène comp 200mg | 1 |
0.7%
|
|
| Mebendazol | 1 |
0.7%
|
|
| Multivitamine cp | 1 |
0.7%
|
|
| PARACETAMOL | 1 |
0.7%
|
|
| Para | 1 |
0.7%
|
|
| Paracetamol | 1 |
0.7%
|
|
| Paracetamol comp | 1 |
0.7%
|
|
| Perfalgan inj | 1 |
0.7%
|
|
| Phliso | 1 |
0.7%
|
|
| Prunex pomade | 1 |
0.7%
|
|
| QUININE | 1 |
0.7%
|
|
| SERINGUE. GANT | 1 |
0.7%
|
|
| Seringue 5cc | 1 |
0.7%
|
|
| Sparadrap | 2 |
1.4%
|
|
| Sparadrap, ampi inj | 1 |
0.7%
|
|
| acide adcorbique | 1 |
0.7%
|
|
| albendazole | 2 |
1.4%
|
|
| albendazole sirop | 1 |
0.7%
|
|
| amoxiciline | 1 |
0.7%
|
|
| amoxiciline gel | 1 |
0.7%
|
|
| amoxicilline | 4 |
2.7%
|
|
| ampi | 2 |
1.4%
|
|
| ampi injec. seringue 5cc | 1 |
0.7%
|
|
| artesunate amodiaquine | 1 |
0.7%
|
|
| asl | 2 |
1.4%
|
|
| asl 900 | 1 |
0.7%
|
|
| bande | 2 |
1.4%
|
|
| betadine | 2 |
1.4%
|
|
| butyl cp | 1 |
0.7%
|
|
| carbotoux sirop | 1 |
0.7%
|
|
| chlor | 1 |
0.7%
|
|
| chlor,para,amoxi,quinine | 1 |
0.7%
|
|
| compresse | 1 |
0.7%
|
|
| diasepam et metopimenzine | 1 |
0.7%
|
|
| diclo | 1 |
0.7%
|
|
| diclo injectable | 1 |
0.7%
|
|
| diclofenac | 2 |
1.4%
|
|
| gant | 1 |
0.7%
|
|
| gants | 2 |
1.4%
|
|
| glucosé isotonique | 1 |
0.7%
|
|
| h | 1 |
0.7%
|
|
| hpv, ASL | 1 |
0.7%
|
|
| hydrocortisone inj | 1 |
0.7%
|
|
| hydroxide | 1 |
0.7%
|
|
| ibuprofene | 1 |
0.7%
|
|
| implants | 1 |
0.7%
|
|
| mag 2 | 1 |
0.7%
|
|
| metro ovule | 1 |
0.7%
|
|
| metronidazole | 1 |
0.7%
|
|
| mucanazole | 1 |
0.7%
|
|
| para | 1 |
0.7%
|
|
| paracetamol | 3 |
2%
|
|
| paracetamol comp | 1 |
0.7%
|
|
| perfalgan | 2 |
1.4%
|
|
| perfuseur | 1 |
0.7%
|
|
| phloro injectable | 1 |
0.7%
|
|
| phloroglucinole | 1 |
0.7%
|
|
| ploro | 1 |
0.7%
|
|
| ploroglycinol | 1 |
0.7%
|
|
| rien | 1 |
0.7%
|
|
| seringue | 5 |
3.4%
|
|
| seringue 10cc | 1 |
0.7%
|
|
| viscid gel | 1 |
0.7%
|
|
| vita c | 1 |
0.7%
|
|
| vitamine c | 2 |
1.4%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.